This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2017 Aug 29;70(9):1200.

doi: 10.1016/j.jacc.2017.05.074.

Reply: Ezetimibe, Risk Stratification, and Secondary Prevention

Erin A Bohula, David A Morrow, Robert P Giugliano, Christopher P Cannon, Eugene Braunwald

PMID: 28838375
DOI: 10.1016/j.jacc.2017.05.074

Free article

Comment

Reply: Ezetimibe, Risk Stratification, and Secondary Prevention

Erin A Bohula et al. J Am Coll Cardiol. 2017.

Free article

. 2017 Aug 29;70(9):1200.

doi: 10.1016/j.jacc.2017.05.074.

Authors

Erin A Bohula, David A Morrow, Robert P Giugliano, Christopher P Cannon, Eugene Braunwald

PMID: 28838375
DOI: 10.1016/j.jacc.2017.05.074

No abstract available

PubMed Disclaimer

Comment on

Atherothrombotic Risk Stratification and Ezetimibe for Secondary Prevention.
Bohula EA, Morrow DA, Giugliano RP, Blazing MA, He P, Park JG, Murphy SA, White JA, Kesaniemi YA, Pedersen TR, Brady AJ, Mitchel Y, Cannon CP, Braunwald E. Bohula EA, et al. J Am Coll Cardiol. 2017 Feb 28;69(8):911-921. doi: 10.1016/j.jacc.2016.11.070. J Am Coll Cardiol. 2017. PMID: 28231942
Ezetimibe, Risk Stratification, and Secondary Prevention.
DuBroff RJ. DuBroff RJ. J Am Coll Cardiol. 2017 Aug 29;70(9):1199. doi: 10.1016/j.jacc.2017.04.074. J Am Coll Cardiol. 2017. PMID: 28838374 No abstract available.

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations